Literature DB >> 19577851

Evidence for a key role of steroids in the modulation of pain.

Ayikoe G Mensah-Nyagan1, Laurence Meyer, Véronique Schaeffer, Cherkaouia Kibaly, Christine Patte-Mensah.   

Abstract

Neurotransmitters such as glutamate, substance P, serotonin and gamma-aminobutyric acid pivotally control pain mechanisms. It is also well known that inflammatory and/or neuropathic pain may depend on the action of diverse cytokines and other molecules including eicosanoids, endorphins, calcitonin-gene related peptide, free radicals and transcription factors. Because steroids control the development, activities and plasticity of the nervous system, these compounds are of particular interest in the modulation of pain. The paper discusses various data supporting the existence of key regulatory effects of steroids in the control of pain. In particular, we analyzed three categories of observations which historically contributed to demonstrate that endogenous and synthetic steroids play a crucial role in the regulation of neurobiological processes involved in pain sensation. The first series of data, which present the chemical characteristics enabling steroids to act on several tissues, also summarize pertinent results supporting the modulation of pain sensation by steroidal compounds. The second category of data evokes psychosocial, fundamental and clinical results suggesting the existence of sex steroid-based differences in pain perception. Finally, we discuss recent evidence showing the endogenous production of neurosteroids and their effects in the spinal cord which crucially controls pain transmission. Taken together, the data reviewed herein suggest that future investigations aiming to develop effective steroid-based strategies against chronic pain must integrate in a complementary manner anti-inflammatory properties of steroids, sex steroid-induced dimorphism in pain perception and regulatory effects exerted by endogenous neurosteroids in pain neural circuits.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19577851     DOI: 10.1016/j.psyneuen.2009.06.004

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  35 in total

1.  Vasopeptidase inhibitor ilepatril (AVE7688) prevents obesity- and diabetes-induced neuropathy in C57Bl/6J mice.

Authors:  Lawrence Coppey; Eric Davidson; Bao Lu; Craig Gerard; Mark Yorek
Journal:  Neuropharmacology       Date:  2010-09-16       Impact factor: 5.250

2.  Mapping two neurosteroid-modulatory sites in the prototypic pentameric ligand-gated ion channel GLIC.

Authors:  Wayland W L Cheng; Zi-Wei Chen; John R Bracamontes; Melissa M Budelier; Kathiresan Krishnan; Daniel J Shin; Cunde Wang; Xin Jiang; Douglas F Covey; Gustav Akk; Alex S Evers
Journal:  J Biol Chem       Date:  2018-01-04       Impact factor: 5.157

3.  Role of Preoperative Dexamethasone Nebulization in Reducing Bougie Complications Encountered After Sleeve Gastrectomy: a Prospective Double-Blind Control Interventional Study.

Authors:  Mahmoud Almustafa; Firas Obeidat; Ayman Mismar; Mohammad Rashdan; Khaled Jabaiti; Saif Aldeen Alryalat; Dalia Al-Hardan; Aiman Suleiman
Journal:  Obes Surg       Date:  2020-02       Impact factor: 4.129

4.  Evidences for antinociceptive effect of 17-α-hydroxyprogesterone caproate in carpal tunnel syndrome.

Authors:  Federica Ginanneschi; Paolo Milani; Georgios Filippou; Mauro Mondelli; Bruno Frediani; Roberto C Melcangi; Alessandro Rossi
Journal:  J Mol Neurosci       Date:  2011-11-24       Impact factor: 3.444

5.  Steroids as pain relief adjuvants.

Authors:  Melissa Vyvey
Journal:  Can Fam Physician       Date:  2010-12       Impact factor: 3.275

6.  The sticky issue of neurosteroids and GABA(A) receptors.

Authors:  Mariangela Chisari; Lawrence N Eisenman; Douglas F Covey; Steven Mennerick; Charles F Zorumski
Journal:  Trends Neurosci       Date:  2010-04-19       Impact factor: 13.837

Review 7.  Road map for pain management in pancreatic cancer: A review.

Authors:  Marie José Lahoud; Hampig Raphael Kourie; Joelle Antoun; Lana El Osta; Marwan Ghosn
Journal:  World J Gastrointest Oncol       Date:  2016-08-15

8.  Diminished neurokinin-1 receptor availability in patients with two forms of chronic visceral pain.

Authors:  Johanna M Jarcho; Natasha A Feier; Alberto Bert; Jennifer A Labus; Maunoo Lee; Jean Stains; Bahar Ebrat; Stephanie M Groman; Kirsten Tillisch; Arthur L Brody; Edythe D London; Mark A Mandelkern; Emeran A Mayer
Journal:  Pain       Date:  2013-03-05       Impact factor: 6.961

9.  Opioid use in patients with rheumatoid arthritis 2005-2014: a population-based comparative study.

Authors:  Jorge A Zamora-Legoff; Sara J Achenbach; Cynthia S Crowson; Megan L Krause; John M Davis; Eric L Matteson
Journal:  Clin Rheumatol       Date:  2016-03-29       Impact factor: 2.980

Review 10.  Allopregnanolone and Progesterone in Experimental Neuropathic Pain: Former and New Insights with a Translational Perspective.

Authors:  Susana Laura González; Laurence Meyer; María Celeste Raggio; Omar Taleb; María Florencia Coronel; Christine Patte-Mensah; Ayikoe Guy Mensah-Nyagan
Journal:  Cell Mol Neurobiol       Date:  2018-09-05       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.